NCT00912366

Brief Summary

Assessment of VATS versus standard open surgery for treatment of non small cell lung cancer.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2009

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2009

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 1, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 3, 2009

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2010

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2010

Completed
Last Updated

July 27, 2015

Status Verified

July 1, 2015

Enrollment Period

1 year

First QC Date

June 1, 2009

Last Update Submit

July 23, 2015

Conditions

Keywords

VATSLung cancerNSCLC

Outcome Measures

Primary Outcomes (2)

  • Assess hospital length of stay (LOS).

    1 time point (discharge)

  • Pain Scale Evaluation

    5 time points out to 6 months

Secondary Outcomes (2)

  • Assess quality of life.

    2 time points out to 6 months

  • Assess peri-operative and post-operative complications.

    5 time points out to 6 months.

Study Arms (2)

Group A

VATS

Procedure: Lobectomy

Group B

Open Surgery

Procedure: Lobectomy

Interventions

LobectomyPROCEDURE

Assessment of VATS versus open surgery.

Also known as: CVATS, HVATS
Group AGroup B

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Subjects referred for lobectomies at the hospital.

You may qualify if:

  • Subject must be 18 years of age or older.
  • Subject must have been clinically diagnosed with stage I to stage IIA non small cell lung cancer measuring and judged to be resectable.
  • Subject must be able to tolerate general anesthesia, and have cardiopulmonary reserve to tolerate a lobectomy

You may not qualify if:

  • Subject is pregnant (documented by pregnancy test) or breastfeeding.
  • Subject has other severe illnesses that would preclude surgery such as
  • Unstable angina
  • Myocardial Infarction within 3 months
  • Coronary Artery Bypass Graft Surgery
  • Subject has other active cancers
  • Subject is unable to comply with any of the following:
  • Study requirements
  • Give valid informed consent
  • Follow-up schedule

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

New York University School of Medicine

New York, New York, 10016, United States

Location

MeSH Terms

Conditions

Carcinoma, Non-Small-Cell LungLung Neoplasms

Interventions

Anterior Temporal Lobectomy

Condition Hierarchy (Ancestors)

Carcinoma, BronchogenicBronchial NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Surgical Procedures, OperativeNeurosurgical Procedures

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 1, 2009

First Posted

June 3, 2009

Study Start

May 1, 2009

Primary Completion

May 1, 2010

Study Completion

December 1, 2010

Last Updated

July 27, 2015

Record last verified: 2015-07

Locations